Article History
Accepted: 4 February 2022
First Online: 1 April 2022
Declarations
:
: Dr. Holdridge serves on the advisory boards for Amgen, Teva, and Lundbeck. She is on the speaker’s bureau for Allergan/Abbvie, Amgen/Novartis, Biohaven, Lilly, Lundbeck, and Teva pharmaceuticals. Dr. Kuruvilla serves on the advisory boards for Theranica, Allergan/Abbvie, Lilly, Amgen/Novartis. She is a consultant for Alphasites consulting, Cefaly, Neurolief, Theranica, Nowwhat media, KX advisors. She is on the speaker’s bureau for Allergan/Abbvie, Lilly, Amgen/Novartis, Biohaven, American headache society, CME meeting. She has provided clinical trial support for Cefaly and Neurolief. She is on the editorial board for Healthline and a contributing author for Headline and WebMD/Medscape. Dr. Johnson serves on the advisor boards for Lundbeck, Teva, and Lilly. She is on the speaker’s bureau for Allergan/Abbvie, Biohaven, Lundbeck, Lilly, and Teva pharmaceuticals.
: This article does not contain any studies with human or animal subjects performed by the authors.